Rchr
J-GLOBAL ID:202201012392317618   Update date: Mar. 09, 2026

Anraku tsutomu

アンラク ツトム | Anraku tsutomu
Affiliation and department:
Papers (12):
  • Fumio Ishizaki, Kaede Hiruma, Yusuke Tani, Hideaki Sugino, Tatsuro Sanami, Tsutomu Anraku, Masahiro Ikeda, Masayuki Tasaki, Kazuhide Saito, Yoshihiko Tomita. Late-Onset Bone Metastasis 46 Years After Initial Surgery for Pheochromocytoma: A Case Report. IJU case reports. 2025. 8. 5. 533-538
  • Kaede Hiruma, Masayuki Tasaki, Tsutomu Anraku, Masahiro Ikeda, Kazuhide Saito, Yoshifumi Shimada, Yoshihiko Tomita. A Case of Giant Neobladder Stone of 5 Kg. IJU case reports. 2025. 8. 3. 281-284
  • Tsutomu Anraku, Masaki Murata, Hiroo Kuroki, Akira Kazama, Yuko Shirono, Masayuki Tasaki, Vladimir Bilim, Yoshihiko Tomita. Selective HDAC6 Inhibition Has the Potential for Anti-Cancer Effect in Renal Cell Carcinoma. Journal of personalized medicine. 2024. 14. 7
  • Yuko Shirono, Vladimir Bilim, Tsutomu Anraku, Hiroo Kuroki, Akira Kazama, Masaki Murata, Kaede Hiruma, Yoshihiko Tomita. Targeting Pro-Survival Autophagy Enhanced GSK-3β Inhibition-Induced Apoptosis and Retarded Proliferation in Bladder Cancer Cells. Current oncology (Toronto, Ont.). 2023. 30. 6. 5350-5365
  • Tsutomu Anraku, Hideki Hashidate, Asa Nakahara, Tomoyuki Imai, Yoshiaki Kawakami. Sarcomatoid urothelial carcinoma of the renal pelvis treated with immunotherapy. BMC urology. 2023. 23. 1. 38-38
more...
MISC (3):
Professional career (1):
  • MD (Niigata University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page